Sequenom Sells MassArray System to Quest Diagnostics | GenomeWeb

NEW YORK, March 7 – Sequenom has sold a MassArray system to genetic testing giant Quest Diagnostics, Sequenom said Wednesday.

Quest will use the MassArray system to identify disease-associated genetic variations and to determine susceptibility to hereditary conditions. The system has been installed at Nichols Institute, Quest's center for research and development, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.